y 27632 has been researched along with oxymatrine in 1 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (oxymatrine) | Trials (oxymatrine) | Recent Studies (post-2010) (oxymatrine) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 412 | 16 | 270 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Deng, S; Fan, H; Liu, X; Liu, Y; Shou, Z; Tang, Q; Wang, Y; Wu, H; Xu, M; Yu, T; Zhang, M | 1 |
1 other study(ies) available for y 27632 and oxymatrine
| Article | Year |
|---|---|
Protective effects of oxymatrine against DSS-induced acute intestinal inflammation in mice via blocking the RhoA/ROCK signaling pathway.
Topics: Alkaloids; Amides; Animals; Anti-Inflammatory Agents; Cell Differentiation; Cell Proliferation; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Forkhead Transcription Factors; Gene Expression Regulation; Humans; Interleukins; Male; Mice; Mice, Inbred BALB C; Oxidative Stress; Pyridines; Quinolizines; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; T-Lymphocytes, Regulatory; Th17 Cells; Treatment Outcome | 2019 |